Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 4

eBook: US $89 Special Offer (PDF + Printed Copy): US $167
Printed Copy: US $122
Library License: US $356
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-1-68108-482-4 (Print)
ISBN: 978-1-68108-481-7 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810848171170401

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The fourth volume of the book brings forth reviews on biomarkers and new drugs used for treating gastrointestinal cancer and breast cancer. The volume also covers the topics of adjuvant therapy, cancer nanodrugs and the role of adiponectin and dicycloplatin in cancer therapy.

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Abid H. Banday
Department of Chemistry and Biochemistry
University of Arizona
Tucson 85721
USA
/
Department of Chemistry
Islamia College of science and Commerce
Hawal, Srinagar 190002
India


Angelos Evangelopoulos
Biologist
Evangelismos General Hospital
Athens
Greece


Andrea Lampis
Centre for Molecular Pathology
The Institute of Cancer Research London & Sutton
Sutton
United Kingdom


Andrea Nicolini
Department of Oncology, Transplantations and New Technologies in Medicine
University of Pisa
Italy


Christos Kazazis
Honorary Lecturer at Leicester University
Leicester
UK


Debra L. Zynger
Department of Pathology
Division of Genitourinary Pathology, The Ohio State University
Columbus, OH 43210
USA


Eleni Geladari
Internist
Evangelismos General Hospital
Athens
Greece


Handi Cao
State Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy
The University of Hong Kong
Hong Kong
China


Iskren Kotzev
University Hospital St. Marina
Varna
Bulgaria


Jens C. Hahne
Centre for Molecular Pathology
The Institute of Cancer Research London & Sutton
Sutton
United Kingdom


Jie Chen
State Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy
The University of Hong Kong
Hong Kong
China


Jing Liu
Beijing Key Lab of CryoBiomedical Engineering and Key Lab of Cryogenics
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
Beijing, 100190
China
/
Department of Biomedical Engineering
Tsinghua University
Beijing, 100084
China


Mengjia Dou
Beijing Key Lab of CryoBiomedical Engineering and Key Lab of Cryogenics
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
Beijing, 100190
China
/
Department of Thermal energy and Power engineering
University of Science & Technology
Beijing, 100083
China


Milko Mirchev
University Hospital St. Marina
Varna
Bulgaria


Ming Liu
State Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy
The University of Hong Kong
Hong Kong
China


Natalia G. Vallianou
Consultant in Internal Medicine
Evangelismos General Hospital
Athens
Greece


Nicola Valeri
Centre for Molecular Pathology
The Institute of Cancer Research London & Sutton
Sutton
United Kingdom
/
Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital London & Sutton
Sutton
United Kingdom


Paola Ferrari
Department of Oncology, Transplantations and New Technologies in Medicine
University of Pisa
Italy


Pier Mario Biava
Scientific Institute of Research and Care Multimedica
Milan
Italy


Syed Irtiqa Urfi
Department of Chemistry
Islamia College of science and Commerce
Hawal, Srinagar 190002
India


Victor J. Hruby
Department of Chemistry and Biochemistry
University of Arizona
Tucson 85721
USA


Wei Rao
Beijing Key Lab of CryoBiomedical Engineering and Key Lab of Cryogenics
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
Beijing, 100190
China


Yi Hou
Beijing Key Lab of CryoBiomedical Engineering and Key Lab of Cryogenics
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
Beijing, 100190
China
/
Department of Thermal energy and Power engineering
University of Science & Technology
Beijing, 100083
China


Yu Wang
State Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy
The University of Hong Kong
Hong Kong
China




RELATED BOOKS

.Topics in Anti-Cancer Research.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.